Neogen (NEOG) Rebounds As Margin Recovery Raises The Question Of Value
Neogen (NEOG) has drawn fresh attention after its recent share move, with the stock closing at $11.89 as of 8 September 2026. Investors are weighing that price against the company’s mixed return profile.
Recent trading has come on the back of a strong run, with Neogen posting a 90 day share price return of 29.66% and a year to date share price return of 69.86%. However, the 5 year total shareholder return has fallen 71.40%, which indicates that momentum has been positive in the short term while long term holders still face sizeable losses.
Compare Neogen’s recent rebound with other potential turnaround stories by exploring a curated list of 17 high quality undiscovered gems while this momentum is still in focus.
Neogen now appears to be a stronger business on the surface, with food and animal safety products and global reach. Yet the share price reset raises a sharper question: Is that quality already baked into today’s valuation, or not?
Most Popular Narrative: 8.5% Undervalued
Neogen’s most followed narrative pegs fair value at $13.00 against the recent $11.89 close, which frames the current rebound as still below that reference point and puts the focus on what needs to go right operationally.
Operational improvements and automation at the new Petrifilm production facility, alongside targeted actions to reduce inefficiencies in sample collection and inventory management, are expected to drive gross margin and EBITDA margin improvements over the coming quarters as execution stabilizes and overhead absorption rates improve.
Curious what is built into that $13.00 figure. The narrative leans on steady revenue, a sharp swing from losses to healthy margins, and a premium future earnings multiple. Want to see which assumptions really carry the weight in that fair value call.
Result: Fair Value of $13.00 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
Still, Neogen’s story can fray if integration problems at the 3M Food Safety unit drag on, or if ongoing tariff and trade pressures keep squeezing profitability.
Find out about the key risks to this Neogen narrative.
Next Steps
If this Neogen setup leaves you slightly conflicted, consider acting quickly and pressure testing the numbers, assumptions, and risks yourself before sentiment shifts. To go deeper into the risk picture, start with the 1 important warning sign.
Looking for more Neogen style investment ideas?
If Neogen has sharpened your focus, do not stop here. Use the Simply Wall Street Screener to quickly uncover fresh opportunities that match your own risk and return priorities.
- Target potential mispricings by reviewing companies screened as 49 high quality undervalued stocks before the rest of the market fully pays attention.
- Prioritize resilience and focus on stability by filtering for 82 resilient stocks with low risk scores that still offer meaningful upside potential.
- Strengthen the defensive side of your portfolio by scanning a list of solid balance sheet and fundamentals (24 results) before capital chases the same familiar tickers.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com